Literature DB >> 30515243

Eye care in the intensive care unit.

Benjamin J Hearne1, Elewys G Hearne2, Hugh Montgomery3, Susan L Lightman4.   

Abstract

Ocular surface disease is common in the intensive care population with 20-42% of patients developing corneal epithelial defects. The ocular surface is normally protected by the ability to produce tears, to blink and to close the eyes with rest or sleep. All of these mechanisms can be disrupted in the intensive care population, increasing the risk of developing ocular surface disease. Despite the scale of the problem, eye-care protocols are commonly not instigated and documentation of eye care is often poor. This review details the risk factors for developing ocular surface disease. It also provides evidence-based guidance on protecting the eyes in vulnerable patients, identifying diseases affecting the eye in intensive care patients and delivering the best treatment to the eye. There is growing evidence that adherence to a correctly performed eye-care guideline prevents the majority of corneal problems encountered in the intensive care unit.

Entities:  

Keywords:  Eye care; eye disease; intensive care; ocular surface disease; ophthalmology

Year:  2018        PMID: 30515243      PMCID: PMC6259085          DOI: 10.1177/1751143718764529

Source DB:  PubMed          Journal:  J Intensive Care Soc        ISSN: 1751-1437


  14 in total

1.  Ocular surface disease in intensive care unit patients.

Authors:  F Mercieca; P Suresh; A Morton; A Tullo
Journal:  Eye (Lond)       Date:  1999-04       Impact factor: 3.775

2.  Preventing exposure keratopathy in the critically ill: a prospective study comparing eye care regimes.

Authors:  D G Ezra; G Lewis; M Healy; A Coombes
Journal:  Br J Ophthalmol       Date:  2005-08       Impact factor: 4.638

Review 3.  Corneal protection during general anesthesia for nonocular surgery.

Authors:  Andre Grixti; Maziar Sadri; Mark T Watts
Journal:  Ocul Surf       Date:  2013-01-29       Impact factor: 5.033

4.  Eye care for patients receiving neuromuscular blocking agents or propofol during mechanical ventilation.

Authors:  S B Lenart; J A Garrity
Journal:  Am J Crit Care       Date:  2000-05       Impact factor: 2.228

5.  Corneal injuries: incidence and risk factors in the Intensive Care Unit.

Authors:  Andreza Werli-Alvarenga; Flávia Falci Ercole; Fernando Antônio Botoni; José Aloísio Dias Massote Mourão Oliveira; Tânia Couto Machado Chianca
Journal:  Rev Lat Am Enfermagem       Date:  2011 Sep-Oct

6.  Development of a new eye care guideline for critically ill patients.

Authors:  Deborah Dawson
Journal:  Intensive Crit Care Nurs       Date:  2005-04       Impact factor: 3.072

7.  Ocular surface bacterial colonisation in sedated intensive care unit patients.

Authors:  E K Mela; E G Drimtzias; M K Christofidou; K S Filos; E D Anastassiou; S P Gartaganis
Journal:  Anaesth Intensive Care       Date:  2010-01       Impact factor: 1.669

8.  Nosocomial bacterial eye infections in intensive-care units.

Authors:  E Hilton; A A Adams; A Uliss; M L Lesser; S Samuels; F D Lowy
Journal:  Lancet       Date:  1983-06-11       Impact factor: 79.321

Review 9.  Eye care in the intensive care unit: narrative review and meta-analysis.

Authors:  Jamie B Rosenberg; Lewis A Eisen
Journal:  Crit Care Med       Date:  2008-12       Impact factor: 7.598

10.  Hypotension-induced blindness in haemodialysis patients.

Authors:  Shveta Bansal; Alec Ansons; Mandagere Vishwanath
Journal:  Clin Kidney J       Date:  2014-04-15
View more
  7 in total

1.  Evaluation of eye care and ocular findings in critically ill COVID-19 patients.

Authors:  Zarife Ekici Gok; Abdullah Gok; Leman Acun Delen; Umut S Kasapoglu; Esra Gurbuz; Kayhan Mutlu
Journal:  Int J Clin Pract       Date:  2021-10-03       Impact factor: 3.149

2.  Effectiveness of lubratex and vitamin A on ocular surface disorders in ICU patients: A randomized clinical trial.

Authors:  Mitra Badparva; Mohammad Veshagh; Farideh Khosravi; Abbas Mardani; Hossein Ebrahimi
Journal:  J Intensive Care Soc       Date:  2020-03-31

3.  Drug-related problems identified during pharmaceutical care interventions in an intensive care unit at a tertiary university hospital.

Authors:  Vichapat Tharanon; Krongtong Putthipokin; Phantipa Sakthong
Journal:  SAGE Open Med       Date:  2022-04-19

4.  Hydralazine-induced vasculitis presenting with ocular manifestations.

Authors:  Vivian S Hawn; Thomas A Vo; David Flomenbaum; Richard P Gibralter
Journal:  Am J Ophthalmol Case Rep       Date:  2022-04-10

5.  Transient facial nerve palsy following dental local anaesthesia.

Authors:  Thomas Jenyon; Jesse Panthagani; David Green
Journal:  BMJ Case Rep       Date:  2020-09-07

6.  Polyethylene eye-cover versus artificial teardrops in the prevention of ocular surface diseases in comatose patients: A prospective multicenter randomized triple-blinded three-arm clinical trial.

Authors:  Mahnaz Khatiban; Hamid Moradi Amin; Gholamhosein Falahinia; Abbas Moghimbeigi; Mehran Yadollahi
Journal:  PLoS One       Date:  2021-04-01       Impact factor: 3.240

7.  Ocular surface manifestation of COVID-19 and tear film analysis.

Authors:  Alessandro Meduri; Giovanni William Oliverio; Giuseppe Mancuso; Angela Giuffrida; Claudio Guarneri; Emmanuele Venanzi Rullo; Giuseppe Nunnari; Pasquale Aragona
Journal:  Sci Rep       Date:  2020-11-19       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.